Table I.
Substrate/Inhibitor | Km or KI (μM) | Vmax (nmoles/min.mg) | KD (nM) | Ref. | |
---|---|---|---|---|---|
1 | 5HT | 19 ± 4 | 1.6 ±1.0 | 32a | |
2 | DA | 25 ± 7 | 0.8 ± .5 | 32a | |
23.8 ±1.5 | 1.60±0.03 | 33b | |||
3 | NE | 91.5 ±10.5 | 0.95±0.05 | 33c | |
4 | E | 68.4 ±4.7 | 1.13±0.03 | 33c | |
5 | TBZ | 3.2 ×10−3 | 1.3 | 34c | |
6 | RES | 10 × 10−3 | 0.3 ± 0.2 (I) | 35d | |
18 ±10 (II) | |||||
7 | KET | 45 ± 2.4 | 36e | ||
8 | TBZOH | 3.7 × 10−3 | 2.9 | 34c | |
5.8 ± 1.0 | 35d | ||||
16 | 5.5 × 10−3 | 93f |
Determined using resealed granule ghosts using [3H]5HT and [3H]DA in the presence of 100 mM ATP, at pH 7.232.
Determined with resealed granule ghosts using non-radioactive substrates with HPLC-EC in the presence of 10 mM ATP, at pH 7.233.
Determined with [3H]TBZ and [3H]TBZOH at 25 °C34 using bovine granule membranes.
Determined with [3H]TBZOH and [3H]reserpine (sites I & II) using bovine chromaffin granule membrens35.
Determined with [3H]KET at 30 °C using granule memebranes36.
Kd determined using [3H] ketanserin at 0° C and chromaffin granule memebranes93.